Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sexual Transmission of Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00630734
What this trial is testing

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin

Who this might be right for
HIV InfectionsHyperlipidemia
University of Colorado, Denver 32
Not applicableUnknownNCT03860116
What this trial is testing

Evaluation of a Smart Phone App-based Case Management Model Among ART-naive HIV-infected MSM

Who this might be right for
HIV/AIDS
Sun Yat-sen University 600
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Post-approval studies (Phase 4)Study completedNCT01045369
What this trial is testing

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

Who this might be right for
HIV Infections
Therapeutic Concepts 30
Not applicableStudy completedNCT02214173
What this trial is testing

The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV

Who this might be right for
Human Immunodeficiency Virus Infection
University of Miami 47
Not applicableUnknownNCT06019273
What this trial is testing

Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV

Who this might be right for
HIV InfectionCombined Antiretroviral Therapy
First Affiliated Hospital of Zhejiang University 180
Not applicableStudy completedNCT00000873
What this trial is testing

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,400
Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Large-scale testing (Phase 3)Ended earlyNCT03333083
What this trial is testing

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen

Who this might be right for
HIV SeropositivityHIV InfectionsHIV-1-infection
Judit Pich 17
Testing effectiveness (Phase 2)Study completedNCT00000641
What this trial is testing

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT04303156
What this trial is testing

Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Not applicableStudy completedNCT05395754
What this trial is testing

Assessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users

Who this might be right for
STISexually Transmitted DiseasesPre-exposure Prophylaxis
Louisiana State University Health Sciences Center in New Orleans 71
Not applicableStudy completedNCT00034086
What this trial is testing

Study of Anti-HIV Therapy Intensification

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Early research (Phase 1)Study completedNCT04515641
What this trial is testing

Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Early research (Phase 1)Looking for participantsNCT06310551
What this trial is testing

First Time in Human Study of Long Acting VH4524184 Formulations

Who this might be right for
HIV Infections
ViiV Healthcare 372
Post-approval studies (Phase 4)Study completedNCT00108862
What this trial is testing

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Next Page